Plain-English translation of NCT07566351 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Rheumatoid Arthritis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing two medications— and —as add-on treatments for rheumatoid arthritis. Both medications have shown promise in reducing inflammation in the body. The study will compare how well each medication works, along with a placebo (an inactive pill), when added to the standard arthritis medications you're already taking.
Many people with rheumatoid arthritis continue to have active disease and inflammation even while taking standard treatments. This trial exists to see whether adding one of these medications might help control the disease better and improve quality of life for patients who aren't getting enough relief from their current therapy.
You likely qualify if…
You likely don't qualify if…
You will join one of three groups: one taking , one taking , or one taking a placebo—all added to your regular arthritis medications. The study lasts three months, during which you'll take your assigned medication daily and have your disease activity, inflammation levels, and symptoms monitored through clinic visits and blood tests. Neither you nor the researchers will know which group you're in, which helps ensure fair results.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Egypt